Prokidney (PROK) Tax Provisions (2021 - 2025)
Prokidney (PROK) reported Tax Provisions of -$1.6 million for Q4 2025, down 193.13% year-over-year from $1.7 million in Q4 2024, and down 383.04% quarter-over-quarter from $560000.0 in Q3 2025.
Prokidney (PROK) Tax Provisions (2021 - 2025) Analysis & Trends
Prokidney (PROK) has 5 years of Tax Provisions data on file, last reported at -$1.6 million in Q4 2025.
- Tax Provisions for Q4 2025 came in at -$1.6 million, down 193.13% year-over-year; the trailing twelve-month figure through Mar 2026 was -$177000.0 (down 68.57% YoY), and the FY2025 annual result was $414000.0, up 169.23% from the prior year.
- Tax Provisions slipped to -$1.6 million in Q4 2025 per PROK's latest filing, from $560000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $2.8 million in Q4 2023 and troughed at -$2.3 million in Q3 2024.
- A 5-year average of $375666.7 and a median of $575500.0 in 2025 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2022 and 2025: Tax Provisions sank 1207.02% in 2022, then surged 1614.29% in 2025.
- A 5-year view of Tax Provisions shows it stood at $114000.0 in 2021, then slumped by 1207.02% to -$1.3 million in 2022, then soared by 321.16% to $2.8 million in 2023, then sank by 39.02% to $1.7 million in 2024, then sank by 193.13% to -$1.6 million in 2025.
- Business Quant data shows PROK's Tax Provisions at -$1.6 million in Q4 2025, $560000.0 in Q3 2025, and $848000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Prokidney | 259.01 Mn | 1.55 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.59 Mn |
| Sep 30, 2025 | 560,000.00 |
| Jun 30, 2025 | 848,000.00 |
| Mar 31, 2025 | 591,000.00 |
| Dec 31, 2024 | 1.70 Mn |
| Sep 30, 2024 | -2.34 Mn |
| Jun 30, 2024 | -56,000.00 |
| Mar 31, 2024 | 98,000.00 |
| Dec 31, 2023 | 2.79 Mn |
| Sep 30, 2023 | 913,000.00 |
| Jun 30, 2023 | 965,000.00 |
| Mar 31, 2023 | 1.33 Mn |
| Dec 31, 2022 | -1.26 Mn |
| Sep 30, 2022 | -75,000.00 |
| Jun 30, 2022 | 1.22 Mn |
| Mar 31, 2022 | 1.01 Mn |
| Dec 31, 2021 | 114,000.00 |
| Sep 30, 2021 | -60,000.00 |